Canine atopic dermatitis is a chronic allergic skin disease affecting 10-15% of dogs, causing persistent itch, secondary infections, and significantly impaired quality of life without appropriate long-term management.
Canine atopic dermatitis welfare impact is chronic and cumulative. Dogs with untreated or under-treated atopy experience constant itch — a deeply unpleasant sensation that disrupts sleep, prevents normal rest, and causes behavioural changes including irritability, reduced activity, and secondary pain from self-trauma. Owners often underestimate the suffering involved because itching, unlike pain, is not associated with obvious distress behaviours like vocalisation. The psychological welfare cost of chronic itch is significant: dogs with atopy show elevated anxiety measures and behavioural changes consistent with reduced wellbeing. Management requires a long-term commitment rather than episodic treatment — atopy cannot be cured, only controlled. Combinations of targeted anti-itch medication, regular medicated bathing, secondary infection treatment, and environmental modification form the management framework. Allergen immunotherapy, while requiring 12-18 months for full effect, can achieve long-term reduction in allergen sensitivity and reduced medication dependence.